Melanoma Stage IIIC

specific

Stage IIIC includes: (T0, N2b, N2c, N3b or N3c); (T1a-T3a, N2c or N3a/b/c, M0); (T3b/T4a, Any N greater than or equal to N1, M0); (T4b, N1a-N2c, M0). T0: No evidence of primary tumor (e.g., unknown primary or completely regressed melanoma). Thickness: Not applicable. Ulceration status: Not applicable. T1a: Tumor measuring less than 0.8 mm in thickness. Ulceration status: Without ulceration. T1b: Tumor measuring less than 0.8 mm in thickness with ulceration, or 0.8-1.0 mm with or without ulcerati

19

Centers

19

Active Trials

Cancer Funding

Top Centers for Melanoma Stage IIIC(19)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
52.6
2
NCI Comprehensive
Active Research Program
52.6
3
NCI Comprehensive
Active Research Program
52.6
4
NCI Comprehensive
Active Research Program
52.6
5
NCI Comprehensive
Active Research Program
52.6
6
NCI Comprehensive
Active Research Program
52.6
752.6
8
NCI Comprehensive
Active Research Program
52.6
9
NCI Comprehensive
Active Research Program
52.6
10
NCI Comprehensive
Active Research Program
52.6
11
NCI Comprehensive
Active Research Program
52.6
12
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
52.6
13
Active Research Program
52.6
14
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
52.6
15
Active Research Program
52.6
16
Active Research Program
52.6
17
Active Research Program
52.6
18
Active Research Program
52.6
19
Active Research Program
52.6

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →